332 related articles for article (PubMed ID: 14638915)
21. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
[TBL] [Abstract][Full Text] [Related]
22. SnoN is a cell type-specific mediator of transforming growth factor-beta responses.
Sarker KP; Wilson SM; Bonni S
J Biol Chem; 2005 Apr; 280(13):13037-46. PubMed ID: 15677458
[TBL] [Abstract][Full Text] [Related]
23. [Role of Ski/SnoN protein in the regulation of TGF-beta signal pathway].
Lu ZH; Chen J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):233-6. PubMed ID: 12905729
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of miR-23a inhibits high glucose-induced EMT and renal fibrogenesis by up-regulation of SnoN.
Xu H; Sun F; Li X; Sun L
Hum Cell; 2018 Jan; 31(1):22-32. PubMed ID: 28707079
[TBL] [Abstract][Full Text] [Related]
25. Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor.
Xu W; Angelis K; Danielpour D; Haddad MM; Bischof O; Campisi J; Stavnezer E; Medrano EE
Proc Natl Acad Sci U S A; 2000 May; 97(11):5924-9. PubMed ID: 10811875
[TBL] [Abstract][Full Text] [Related]
26. Kindlin-2 mediates activation of TGF-β/Smad signaling and renal fibrosis.
Wei X; Xia Y; Li F; Tang Y; Nie J; Liu Y; Zhou Z; Zhang H; Hou FF
J Am Soc Nephrol; 2013 Sep; 24(9):1387-98. PubMed ID: 23723426
[TBL] [Abstract][Full Text] [Related]
27. Ski and SnoN: negative regulators of TGF-beta signaling.
Luo K
Curr Opin Genet Dev; 2004 Feb; 14(1):65-70. PubMed ID: 15108807
[TBL] [Abstract][Full Text] [Related]
28. Lack of microRNA-155 ameliorates renal fibrosis by targeting PDE3A/TGF-β1/Smad signaling in mice with obstructive nephropathy.
Xi W; Zhao X; Wu M; Jia W; Li H
Cell Biol Int; 2018 Nov; 42(11):1523-1532. PubMed ID: 30080287
[TBL] [Abstract][Full Text] [Related]
29. SnoN as a novel negative regulator of TGF-β/Smad signaling: a target for tailoring organ fibrosis.
Zeglinski MR; Hnatowich M; Jassal DS; Dixon IM
Am J Physiol Heart Circ Physiol; 2015 Jan; 308(2):H75-82. PubMed ID: 25380815
[TBL] [Abstract][Full Text] [Related]
30. Smad transcriptional corepressors in TGF beta family signaling.
Wotton D; Massagué J
Curr Top Microbiol Immunol; 2001; 254():145-64. PubMed ID: 11190572
[TBL] [Abstract][Full Text] [Related]
31. Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction.
Sato M; Muragaki Y; Saika S; Roberts AB; Ooshima A
J Clin Invest; 2003 Nov; 112(10):1486-94. PubMed ID: 14617750
[TBL] [Abstract][Full Text] [Related]
32. Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression.
Luo DD; Phillips A; Fraser D
Am J Pathol; 2010 Mar; 176(3):1139-47. PubMed ID: 20093492
[TBL] [Abstract][Full Text] [Related]
33. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
Paterson IC; Davies M; Stone A; Huntley S; Smith E; Pring M; Eveson JW; Robinson CM; Parkinson EK; Prime SS
Oncogene; 2002 Feb; 21(10):1616-24. PubMed ID: 11896591
[TBL] [Abstract][Full Text] [Related]
34. Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats.
Marquez-Aguirre A; Sandoval-Rodriguez A; Gonzalez-Cuevas J; Bueno-Topete M; Navarro-Partida J; Arellano-Olivera I; Lucano-Landeros S; Armendariz-Borunda J
J Gene Med; 2009 Mar; 11(3):207-19. PubMed ID: 19189315
[TBL] [Abstract][Full Text] [Related]
35. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
[TBL] [Abstract][Full Text] [Related]
36. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta1 potentiates renal tubular epithelial cell death by a mechanism independent of Smad signaling.
Dai C; Yang J; Liu Y
J Biol Chem; 2003 Apr; 278(14):12537-45. PubMed ID: 12560323
[TBL] [Abstract][Full Text] [Related]
38. Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats.
Chi C; Liu XY; Hou F; Yu XZ; Li CY; Cui LJ; Liu RX; Yin CH
BMC Complement Altern Med; 2018 Feb; 18(1):52. PubMed ID: 29402324
[TBL] [Abstract][Full Text] [Related]
39. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
[TBL] [Abstract][Full Text] [Related]
40. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]